Zum Nutzen internationaler Standards bei der Vergabe von Genpatenten - Eine vergleichende Analyse am Beispiel der EU und Japans
[The benefits of international standards in the awarding of genetic patents - A comparative analysis between the EU and Japan]
The specific characteristics of the R&D system of the modern molecular biotechnology lead to the fact that patent protection for genetic inventions cause almost simultaneously an useful information effect as well as a harmful blocking effect. Within this context, the present papers shows that the current attempts of the U.S., Japan, and the EU to establish consistent standards for patents in the area of genetic engineering, are only scarcely reasonable. Due to national distinctions of cultural and traditional conditions with view to the allocation and usage of property rights, an optimal patent system in Japan is not identical to one in Europe or the U.S.
|Date of creation:||Oct 2003|
|Date of revision:|
|Contact details of provider:|| Postal: Ludwigstraße 33, D-80539 Munich, Germany|
Web page: https://mpra.ub.uni-muenchen.de
More information through EDIRC
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- James Bessen & Eric Maskin, 2009.
"Sequential innovation, patents, and imitation,"
RAND Journal of Economics,
RAND Corporation, vol. 40(4), pages 611-635.
When requesting a correction, please mention this item's handle: RePEc:pra:mprapa:18671. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Joachim Winter)
If references are entirely missing, you can add them using this form.